Petkov O, Orbetsova V, Dakovska L
Cor Vasa. 1985;27(6):464-72.
Blood plasma and myocardial total lipids (TL), cholesterol (Ch), triglycerides (TGL), phospholipids (PhL), as well as plasma free fatty acids (FFA) were studied in 56 male rabbits with experimental thyrotoxic myocardial hypertrophy, induced by Thyreotom (group T14-14 days, T45-45 days). Combinations with Trasicor (TT-14 days) and aminooxyacetic acid (TAOAA-14 days) were also applied. The data showed a significantly lower plasma Ch and TL levels both in T14 and T45 as compared to the control group. The myocardial levels of TGL both in T14 and T45 were significantly higher than in the control group. In the TT group, myocardial Ch tended to decrease. A considerable decrease in plasma and myocardial lipids was found in the TAOAA group. Treatment with Thyreotom with or without Trasicor or AOAA resulted in a decrease of polyunsaturated FA, which was most expressed in the TT group. The combinations with Trasicor and AOAA had a protective effect on thyrotoxic disturbances.
对56只雄性家兔进行了研究,这些家兔因甲状腺切除诱导产生实验性甲状腺毒症性心肌肥大(T14组-14天,T45组-45天),检测了它们的血浆和心肌总脂质(TL)、胆固醇(Ch)、甘油三酯(TGL)、磷脂(PhL)以及血浆游离脂肪酸(FFA)。还应用了与曲美他嗪(TT组-14天)和氨基氧乙酸(TAOAA组-14天)的联合用药。数据显示,与对照组相比,T14组和T45组的血浆Ch和TL水平显著降低。T14组和T45组的心肌TGL水平均显著高于对照组。在TT组中,心肌Ch有下降趋势。在TAOAA组中,血浆和心肌脂质显著减少。无论是否联合曲美他嗪或氨基氧乙酸进行甲状腺切除治疗,都会导致多不饱和脂肪酸减少,这在TT组中表现最为明显。曲美他嗪和氨基氧乙酸的联合用药对甲状腺毒症性紊乱有保护作用。